📢 Publish Your Research for Free - Full APC Waiver, No Hidden Charges. Submit Your Article Today! Submit Now →

Editor Profile

editor profile image is not found.

Dr. Abdulhamid Shafei Fatani, MBBS, BSc, PGDip, MD, PhD

Clinician - Scientist

Present

National Hospital for Neurology & Neurosurgery – (UCLH)

London

United Kingdom

editor profile QR Code is not found.

Dr. Abdulhamid Shafei Fatani is a physician-scientist with a strong clinical background and research expertise across multiple disciplines, including neurosurgery, neurology, pain medicine, regenerative medicine, gene and cell therapy, nanomedicine, Pharamcology and Mendelian randomization.

He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Ministry of National Guards, Saudi Arabia. He subsequently obtained a Postgraduate Diploma in Cell and Gene Therapy in Pediatrics from Great Ormond Street Hospital and the Institute of Child Health (UCLA, USA), followed by a PhD at the National Hospital for Neurology and Neurosurgery, University College London Hospitals (UCLH), United Kingdom. He also holds a bachelor’s degree in laboratory medicine from UQU University.

Dr. Fatani’s research focuses on innovative therapeutic approaches, including nanomedicine-based drug and gene delivery systems, gene therapy for neurological disorders and chronic pain, regenerative medicine, translational neuroscience, and precision medicine. He has authored numerous peer-reviewed publications in internationally recognized journals and has presented his research at national and international scientific conferences across the United Kingdom, Sweden, the United States, and Saudi Arabia, as well as globally.

In addition to his research activities, Dr. Fatani serves as an editorial board member and peer reviewer for several international scientific journals. He has supervised postgraduate research projects involving nanocarriers and gene delivery technologies. His scholarly contributions have received significant academic recognition, including competitive research awards and a growing citation record within the biomedical and translational research communities.

  • Neurosurgery
  • Pharmacology
  • Gene & Cell Therapy
  • Role of inorganic polyphosphate in reactive oxygen species in primary neurons and astrocytes (For submission).
  • Gene therapy for chronic pain syndrome (For submission).
  • Fatani A.S., Schätzlein A.G., Uchegbu I.F., Targeting intracranial tumours with a combination of RNA and chemotherapy, Pharmaceutics, 16(6): 829, June 2024. doi: 10.3390/pharmaceutics16060829. PMID: 38931949; PMCID: PMC11207522.
  • Fatani A.S., Petkova A., Schatzlein A.G., Uchegbu I.F., Dose-dependent delivery of genes to the cerebral cortex via the nasal route, International Journal of Pharmaceutics, 644: 123343, September 2023. doi: 10.1016/j.ijpharm.2023.123343. PMID: 37633538.
  • Fatani A., Al-Rouqi K., Al Towairky J., Ahmed A.E., Al-Jahdali S., Ali Y., Al-Shimemeri A., Al-Harbi A., Baharoon S., Khan M., Al-Jahdali H., Effect of age and gender on prevalence of excessive daytime sleepiness in Saudi population, Journal of Epidemiology and Global Health, 5(4 Suppl 1): S59–66, December 2015. doi: 10.1016/j.jegh.2015.05.005. PMID: 26099548.
  • Abumaree M.H., Al Jumah M.A., Kalionis B., Jawdat D., Al Khaldi A., Abomaray F.M., Fatani A.S., Chamley L.W., Knawy B.A., Human placental mesenchymal stem cells (pMSCs) act as immune suppressive cells by shifting macrophage differentiation from M1 to M2, Stem Cell Reviews, 9(5): 620–641, October 2013. doi: 10.1007/s12015-013-9455-2. PMID: 23812784.
  • Ahmed A.E., Fatani A., Al-Harbi A., Al-Shimemeri A., Ali Y.Z., Baharoon S., Al-Jahdali H., Validation of the Arabic version of the Epworth Sleepiness Scale, Journal of Epidemiology and Global Health, 4(4): 297–302, December 2014. doi: 10.1016/j.jegh.2014.04.004. PMID: 25455647.
  • Elhawary N.A., Bogari N., Jiffri E.H., Rashad M., Fatani A., Tayeb M., TAP1-637G and PSMB9-60H variants influence vitiligo risk in Saudi population, Disease Markers, 2014: 260732, December 2014. doi: 10.1155/2014/260732. PMID: 25548428; PMCID: PMC4273470.
  • Ahmed A.E., Al-Jahdali H., Fatani A., Al-Rouqi K., Al-Jahdali F., Al-Harbi A., Baharoon S., Ali Y.Z., Khan M., Rumayyan A., Effects of age and gender on prevalence of insomnia in Saudi population, Ethnicity & Health, 22(3): 285–294, June 2017. doi: 10.1080/13557858.2016.1244624. PMID: 27846729.
  • Sherbini N.A., Ahmad A., Fatani A., Al-Otaibi K., Al-Jahdali S., Ali Y., Al-Harbi A., Khan M., Baharoon S., Al-Jahdali H., Prevalence and risk factors of restless legs syndrome among Saudi adults, American Journal of Respiratory and Critical Care Medicine, 193: A4226, 2016.
    No content available to display!!!